Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Neoplasms 5 Uterine Cervical Neoplasms 3 Breast Neoplasms 3 Uterine Cervical Dysplasia 2 Urinary Bladder Neoplasms 2 Triple Negative Breast Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Kidney Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Uterine Neoplasms 1 Uterine Diseases 1 Uterine Cervical Diseases 1 Urogenital Neoplasms 1 Urogenital Diseases 1 Skin Neoplasms 1 Sarcoma, Endometrial Stromal 1 Precancerous Conditions 1 Neoplasms by Site 1 Neoplasm Metastasis 1 Liver Neoplasms 1 Leiomyosarcoma 1 Leiomyoma 1 Head and Neck Neoplasms 1 Genital Neoplasms, Female 1 Genital Diseases, Female 1 Genital Diseases 1 Female Urogenital Diseases and Pregnancy Complications 1 Endometrial Neoplasms 1 Colorectal Neoplasms 1

Interventions

telapristone acetate 18 vilaprisan 12 relugolix 11 estradiol, norethindrone drug combination 9 asoprisnil 9 Estradiol 8 elagolix 7 Uterine Myomectomy 7 ulipristal acetate 6 Norethindrone Acetate 6 Leuprolide 5 linzagolix 4 Uterine Artery Embolization 3 Sugars 3 ulipristal 2 Progestins 2 Mifepristone 2 epigallocatechin gallate 1 carbetocin 1 Vitamin D 1 Vitamin B 6 1 Therapeutics 1 Standard of Care 1 Sodium Chloride 1 Robotic Surgical Procedures 1 Radiofrequency Ablation 1 Progesterone 1 Microbial Collagenase 1 Megestrol Acetate 1 Medroxyprogesterone Acetate 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Leiomyoma × Biopsy × Clear all

NCT04214457 2021-09-05

MYOSARC

Igenomix

Leiomyoma, Leiomyosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡